Drug Patent Expirations in January 2014

Drug Patent Expirations for January 2014

TradenameApplicantGeneric NamePatent NumberPatent Expiration
EPIVIR-HBVGlaxosmithklinelamivudineRE39155*PEDJan 2, 2014
MICARDISBoehringer Ingelheimtelmisartan5,591,762Jan 7, 2014
TWYNSTABoehringer Ingelheimamlodipine besylate; telmisartan5,591,762Jan 7, 2014
COMBIPATCHNovartisestradiol; norethindrone acetate6,024,976Jan 7, 2014
GLUCOTROL XLPfizerglipizide5,591,454Jan 7, 2014
VIVELLE-DOTNovartisestradiol6,024,976Jan 7, 2014
MICARDIS HCTBoehringer Ingelheimhydrochlorothiazide; telmisartan5,591,762Jan 7, 2014
RAPAMUNEPf Prism Cvsirolimus5,100,899*PEDJan 7, 2014
MINIVELLENovenestradiol6,024,976Jan 7, 2014
ATACANDAstrazenecacandesartan cilexetil5,534,534*PEDJan 9, 2014
ATACAND HCTAstrazenecacandesartan cilexetil; hydrochlorothiazide5,534,534*PEDJan 9, 2014
PRECEDEXHospiradexmedetomidine hydrochloride4,910,214*PEDJan 15, 2014
SANDOSTATIN LARNovartisoctreotide acetate5,538,739*PEDJan 23, 2014
XYZALUcb Inclevocetirizine dihydrochloride5,698,558*PEDJan 26, 2014
DULERAMerck Sharp Dohmeformoterol fumarate; mometasone furoate6,677,323Jan 27, 2014
NORVIRAbbottritonavir5,541,206*PEDJan 30, 2014
NORVIRAbbvieritonavir5,635,523*PEDJan 30, 2014
KALETRAAbbvielopinavir; ritonavir5,541,206*PEDJan 30, 2014
NORVIRAbbvieritonavir5,541,206*PEDJan 30, 2014
NORVIRAbbvieritonavir5,674,882*PEDJan 30, 2014
BETAXONAlcon Pharms Ltdlevobetaxolol hydrochloride5,540,918*PEDJan 30, 2014
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.

Subscribers have access to valuable datasets, including:

  • Clinical trial information
  • International patent families
  • International patent priority and PCT information
  • Patent maintenance
  • Full-text patent downloads
  • Sales data (top 200 drugs)
  • Paragraph IV challenges
  • Tentative approvals
  • Dynamic search capabilities with data export
  • More…
See the Database Preview and Plan Comparison.
Contact Us with any questions.

Comments are closed.

Do NOT follow this link or you will be banned from the site!
Get email updates

Get new actionable insights and updates from BiotechBlog